News and Press ReleasesPage 2

ImmuniWeb is named a “Best Security Company of the Year” at the Cyber Security Awards 2023 ceremony that took place in London on November 29.

ImmuniWeb is the winner in the “Publisher's Choice in Application Security” category of the 11th Cyber Defense Magazine’s Annual InfoSec Awards series.

The prestigious award recognizes successful companies that create innovation and empower startups in their regions to outpace competitors with rapid growth, creating disruptive but sustainable business.

ImmuniWeb® Neuron Mobile is 100% automated mobile application security testing solution that offers advanced DAST, SAST and SCA scanning capacities with a contractual zero false-positives SLA.

Running about 200,000 daily security scans, the free Community Edition now has an online security test to quickly verify security, privacy and compliance of email servers.

The panel of reputable Judges named ImmuniWeb Discovery a Highly Recommended solution in the “Best Regulatory Compliance Tools and Solutions” category of the prestigious award.

To better protect our customers, partners and users of the free ImmuniWeb® Community Edition, Portal accounts now have Two-Factor Authentication (2FA) enabled by default.

Business Intelligence Group named ImmuniWeb® AI Platform a winner in the highly competitive Application Security category of its 2023 Fortress Cyber Security Award.

Panel of Judges from Cyber Defense Magazine (CDM) named ImmuniWeb a winner in two categories during the 11th Annual Global InfoSec Awards at RSA Conference 2023.

ImmuniWeb presents numerous innovative features and new functionalities that have been successfully implemented in Q1 2023, and are now available to our customers at no additional cost.

Our Attack Surface Management (ASM) product – ImmuniWeb® Discovery – is the Gold Winner in the “Asset Discovery & Management” category of Globee® Cybersecurity Awards 2023.

ImmuniWeb was named a Gold Winner in as many as 10 categories, evidencing the outstanding technical evolution and development of ImmuniWeb® AI Platform made in the last 12 months.